Minghe Luo | Natural Products Biosynthesis | Editorial Board Member

Published on by Biotechnology Scientist

Assoc. Prof. Dr. Minghe Luo | Natural Products Biosynthesis | Editorial Board Member

Associate Professor at Chongqing University of Technology | China

Assoc. Prof. Dr. Minghe Luo is a highly accomplished researcher specializing in natural products chemistry, microbial biosynthesis, medicinal chemistry, and marine-derived bioactive compounds, with a strong scientific record demonstrated by 826 citations, 36 peer-reviewed publications, and an h-index of 18 on Scopus. His research integrates natural product discovery, biosynthetic pathway elucidation, enzymatic function analysis, and bioactivity evaluation, contributing significantly to the development of antibacterial agents, hepatoprotective molecules, siderophores, diketopiperazines, and structurally diverse marine fungal metabolites. Dr. Luo has made major advancements in understanding complex biosynthetic mechanisms, including cytochrome P450–mediated oxidation, polyketide assembly, and enzyme-catalyzed tailoring reactions, highlighted in high-impact journals such as Angewandte Chemie International Edition, Nature Communications, Chemical Engineering Journal, Journal of Natural Products, and Organic Letters. His work also includes innovative studies on deep-sea fungi, Streptomyces species, and marine actinomycetes, leading to the discovery of new anthraquinones, nucleoside antibiotics, and novel polyketide derivatives. As both first author and corresponding author on multiple publications, Dr. Luo has demonstrated strong scientific leadership, editorial judgment, and expertise in guiding research from discovery to mechanistic analysis. He has contributed to several nationally funded research projects and has led investigations into antibacterial natural products and biosynthetic gene clusters, reinforcing his role as an influential scientist in pharmaceutical biotechnology. Dr. Luo’s extensive publication record, multidisciplinary expertise, and consistent scientific impact make him exceptionally well-suited for an Editorial Board Member role in journals focused on natural products, biosynthesis, pharmaceutical chemistry, and microbial biotechnology.

Profiles : Scopus | ORCID | Google Scholar

Featured Publications

Ma, J., Wang, Z., Huang, H., Luo, M., Zuo, D., Wang, B., Sun, A., Cheng, Y. Q., & Ju, J. (2011). Biosynthesis of himastatin: Assembly line and characterization of three cytochrome P450 enzymes involved in the post-tailoring oxidative steps. Angewandte Chemie International Edition. (Cited by: 103)

Shi, S., Zhou, M., Li, X., Hu, M., Li, C., Li, M., Sheng, F., Li, Z., Wu, G., Luo, M., Cui, H., & others. (2016). Synergistic active targeting of dually integrin αvβ3/CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies. Journal of Controlled Release. (Cited by: 92)

Huang, H., Wang, F., Luo, M., Chen, Y., Song, Y., Zhang, W., Zhang, S., & Ju, J. (2012). Halogenated anthraquinones from the marine-derived fungus Aspergillus sp. SCSIO F063. Journal of Natural Products. (Cited by: 88)

Li, Y., Shi, S., Ming, Y., Wang, L., Li, C., Luo, M., Li, Z., Li, B., & Chen, J. (2018). Specific cancer stem cell therapy by albumin nanoparticles functionalized with CD44-mediated targeting. Journal of Nanobiotechnology. (Cited by: 72)

Ming, Y., Li, Y., Xing, H., Luo, M., Li, Z., Chen, J., Mo, J., & Shi, S. (2017). Circulating tumor cells: From theory to nanotechnology-based detection. Frontiers in Pharmacology. (Cited by: 66)

 

Dexin Wang | Synthetic Biology | Editorial Board Member

Published on by Biotechnology Scientist

Dr. Dexin Wang | Synthetic Biology | Editorial Board Member

Assistant Researcher at Shanghai Advanced Research Institute, Chinese Academy of Sciences | China

Dr. Dexin Wang is an emerging researcher in microbial biotechnology, specializing in biopolymer biosynthesis, metabolic engineering, and sustainable bioprocess development. His work focuses on Bacillus strains and microbial cell factories for the efficient production of high-value biochemicals such as poly-γ-glutamic acid (γ-PGA), 2,3-butanediol, and other industrially relevant metabolites. With 133 citations, 12 peer-reviewed publications, and an h-index of 6 on Scopus, Dr. Wang has demonstrated strong scholarly productivity and growing scientific influence. His representative works include breakthroughs in optimizing large-scale fermentation processes, engineering Bacillus tequilensis and Bacillus subtilis strains for enhanced γ-PGA biosynthesis, and developing multienzyme assembly strategies that significantly improve microbial production efficiency. His research contributions also extend to applied biotechnology, where he has contributed to multiple patented technologies involving engineered Bacillus and Klebsiella strains for industrial biochemical production. These achievements highlight his ability to translate fundamental scientific insights into high-impact technological applications. Dr. Wang has actively participated in major research initiatives, including national and regional synthetic biology and metabolic engineering programs, supporting advancements in green chemistry and industrial biotechnology. His consistent output, methodological rigor, and strong collaborative work position him as a valuable contributor to the scientific community. His demonstrated expertise, publication record, and technical leadership make him an excellent candidate for the Editorial Board Member role in biotechnology-focused journals.

Profile : Scopus

Featured Publications

Wang, D., Kim, H., Lee, S., Kim, D.-H., & Joe, M.-H. (2020). High-level production of poly-γ-glutamic acid from untreated molasses by Bacillus siamensis IR10. Microbial Cell Factories.

Wang, D., Kim, H., Lee, S., Kim, D.-H., & Joe, M.-H. (2020). Simultaneous production of poly-γ-glutamic acid and 2,3-butanediol by a newly isolated Bacillus subtilis CS13. Applied Microbiology and Biotechnology.

Wang, D., Oh, B.-R., Lee, S., Kim, D.-H., & Joe, M.-H. (2021). Process optimization for mass production of 2,3-butanediol by Bacillus subtilis CS13. Biotechnology for Biofuels.

Wang, D., Fu, X., Zhou, D., Gao, J., & Bai, W. (2022). Engineering of a newly isolated Bacillus tequilensis BL01 for poly-γ-glutamic acid production from citric acid. Microbial Cell Factories.

Wang, D., Fu, X., Gao, J., Zhao, X., & Bai, W. (2024). Enhancing poly-γ-glutamic acid production in Bacillus tequilensis BL01 through a multienzyme assembly strategy and expression features of glutamate synthesis from Corynebacterium glutamicum. Journal of Agricultural and Food Chemistry.

Eugenia Messina | Cell Factory | Best Researcher Award

Published on by Biotechnology Scientist

Dr. Eugenia Messina | Cell Factory | Best Researcher Award

Research Fellow at University of Bari Aldo Moro | Italy

Dr. Eugenia Messina, a Research Fellow at the University of Bari “Aldo Moro,” Italy, specializes in industrial and environmental biotechnology with a focus on metabolic engineering of yeasts for sustainable bio-based production. Her research primarily explores the genetic and biochemical modification of Yarrowia lipolytica, aiming to optimize microbial systems for the bioconversion of plastic waste into valuable biochemicals. Dr. Messina’s scientific trajectory reflects strong interdisciplinary expertise spanning biochemistry, molecular genetics, and microbial biotechnology. She has collaborated with renowned research institutions such as INRAE (France) and has actively participated in EU-funded projects promoting circular economy models through biological innovation. Her publication record includes notable contributions to Bioresource Technology, Microbial Cell Factories, and Metabolic Engineering, focusing on mitochondrial transport mechanisms, fatty acid biosynthesis, and microbial platform development. She holds 8 Scopus-indexed publications, 110 citations, and an h-index of 6, underscoring her growing academic influence. Dr. Messina is also a co-inventor on a European patent related to metabolic engineering for isocitric acid production, highlighting her translational research impact. Her excellence has been recognized with the HERITAGE 2024 Award and multiple honors from scientific societies. By integrating molecular biology and sustainable bioprocessing, Dr. Messina’s work contributes significantly to advancing green biotechnology and industrial bioengineering, making her an outstanding nominee for the Best Researcher Award.

Profiles : Scopus | ORCID

Featured Publications

Messina, E., Lazar, Z., Barile, S., Moroz, P., Scarcia, P., Antonacci, Y., Fosso, B., Palmieri, L., Pisano, I., & Agrimi, G. (2026). Acetate co-feeding increases ethylene glycol assimilation and glycolic acid production in Yarrowia lipolytica. Bioresource Technology.

Castellani, S., Iaconisi, G. N., Tripaldi, F., Porcelli, V., Trapani, A., Messina, E., Guerra, L., Di Franco, C., Maruccio, G., Monteduro, A. G., Corbo, F., Di Gioia, S., & Trapani, G. (2024). Dopamine and Citicoline-Co-Loaded Solid Lipid Nanoparticles as multifunctional nanomedicines for Parkinson’s disease treatment by intranasal administration. Pharmaceutics.

Di Noia, M. A., Ocheja, O. B., Scarcia, P., Pisano, I., Messina, E., Agrimi, G., Palmieri, L., & Guaragnella, N. (2024). Lack of mitochondrial DNA provides metabolic advantage in yeast osmoadaptation. Biomolecules

Khozov, A. A., Bubnov, D. M., Plisov, E. D., Vybornaya, T. V., Yuzbashev, T. V., Agrimi, G., Messina, E., Stepanova, A. A., Kudina, M. D., Alekseeva, N. V., & Netrusov, A. I. (2023). A study on L-threonine and L-serine uptake in Escherichia coli K-12. Frontiers in Microbiology.

Yuzbasheva, E. Y., Scarcia, P., Yuzbashev, T. V., Messina, E., Kosikhina, I. M., Palmieri, L., Shutov, A. V., Taratynova, M. O., Amaro, R. L., & Palmieri, F. (2021). Engineering Yarrowia lipolytica for the selective and high-level production of isocitric acid through manipulation of mitochondrial dicarboxylate–tricarboxylate carriers. Metabolic Engineering.